Naloxone Education and Receipt of Kit During the Perinatal Period

Abstract

Opioid overdose deaths are a leading cause of maternal mortality in the US, with most occurring postpartum. Naloxone, an opioid antagonist, is an effective method to reverse an opioid overdose. The objective of our study was to examine the provision of naloxone information during prenatal care and identify the proportion of pregnant and postpartum individuals with opioid use disorder (OUD) who had a naloxone kit.